Riskpilot← Back to searchSign inGet full accessBohusmedicin AB
ABActiveOrg 5568442239Södra Fiskebäcksvägen 256General medical practice activities · NACE 8621Est. 20110 employees
Revenue 2024
SEK 0
EBITDA margin
—
-116% vs 2023
Equity ratio
78.1%
Financial strength
Net profit 2024
SEK 119K
-21% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -32K | -116% |
| Net profit | SEK 119K | -21% |
| Total assets | SEK 1,7M | +1% |
| Equity | SEK 1,3M | +10% |
| Employees | 0 | — |
Legal name
Bohusmedicin AB
Org number
5568442239
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 mars 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet, utbildning och personal- uthyrning inom vårdsektorn, dykerimedicin och därmed förenlig verksamhet. Bolaget ska även äga och förvalta aktier och andelar samt övrig fast och lös egendom.
Address
Södra Fiskebäcksvägen 256
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 261 | 274 | 212 | 264 | 0 |
| Staff expenses | — | — | — | −2 | −21 |
| EBITDA | 139 | 150 | 182 | 199 | −32 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 139 | 150 | 182 | 199 | −32 |
| Net financials | 17 | 53 | −35 | 56 | 115 |
| Profit before tax | 117 | 153 | 88 | 191 | 136 |
| Tax | −25 | −32 | −37 | −40 | −17 |
| Net profit | 92 | 121 | 51 | 151 | 119 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 143 | 1 297 | 1 423 | 1 673 | 1 698 |
| Equity | 883 | 1 004 | 1 055 | 1 206 | 1 325 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 168 | 151 | 167 | 202 | 161 |
| Total debt | 168 | 151 | 167 | 202 | 161 |
EBITDA margin
-3197200.0%
This company
15.8%
Market median
-20235543% vs market
20202024
Equity ratio
78.1%
This company
38.2%
Market median
+104% vs market
20202024
Return on equity
9.0%
This company
18.4%
Market median
-51% vs market
20202024
Net profit margin
11919100.0%
This company
8.1%
Market median
+147149283% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bohusmedicin AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Björn Christer Merck | Board of Directors | 0 companies |
| Lisa Gudrun Helena Merck | Deputy Board Member | 0 companies |